16.04.1951
0117 331 3
d.nutt@imperial.ac.uk

Teenistuskäik

Töökohad ja ametid
01.01.2009–...   
Head of Department of Neuropsychopharmacology, Imperial College London
2006–...   
Tartu Ülikool, Arstiteaduskond, projekti põhitäitja (1,00)
01.01.1988–...   
Honorary Consultant Psychiatrist, United Bristol Healthcare Trust
01.01.2003–31.12.2009   
Head of Department of Community Based Medicine
01.01.1994–31.12.2009   
Professor of Psychopharmacology, University of Bristol
01.01.1988–31.12.2009   
Director, Psychopharmacology Unit, University of Bristol
 
 
Haridustee
2002–...   
FMedSci
2002–...   
FRCP
1994–...   
FRCPsych (UK)
1983–...   
MRCPsych (UK)
1982–...   
DM (Oxon)
1981–...   
MA, MB, BChir (Oxon) (by Incorporation).
1977–...   
MRCP (London)
1975–...   
MB BChir (Cantab)
1972–...   
BA (Cantab) 1st in both parts of Medical Sciences Tripos, including part Ib Psychology 2:2 Part II, Physiology
 
 
Teadusorganisatsiooniline ja -administratiivne tegevus
2009−...   
Head of Department of Neuropsychopharmacology, Imperial College London
2003−2009   
Head of the Department of Community Based Medicine
2000−2003   
Dean of Clinical Medicine and Dentistry
1997−2003   
Head of Department of Clinical Medicine
1996−1997   
Head, Division of Psychiatry, University of Bristol
1994−2009   
Professor of Psychopharmacology, University of Bristol
1988−2009   
Director, Psychopharmacology Unit, University of Bristol; Senior Research Fellow in Pharmacology and in Mental Health; Honorary Consultant Psychiatrist, United Bristol Healthcare Trust.
1986−1988   
Fogarty Visiting Scientist NIH and Chief of the Section of Clinical Science, National Institute on Alcohol Abuse and Alcoholism, Bethesda, Maryland.
1985−1986   
Wellcome Senior Fellow in Clinical Science; University Department of Psychiatry, Warneford Hospital, Oxford. Honorary Consultant Psychiatrist.
1983−1985   
Lecturer in Psychiatry, University of Oxford, attached to the Psychopharmacology Research Unit, Littlemore Hospital, Oxford.
1982−1983   
Registrar in Psychiatry on the Oxford Rotational Training Scheme.
1978−1978   
Senior House Officer, Psychiatry, Guy's Hospital
1978−1982   
Clinical Scientist in the MRC Unit of Clinical Pharmacology, Radcliffe Infirmary, Oxford (Professor D G Grahame Smith).
1977−1978   
Senior House Officer, Neurology, St. Mary's Hospital, Paddington
1976−1976   
House Surgeon, Royal Sussex County Hospital, Brighton
1976−1976   
Senior House Officer, Dermatology, Guy's Hospital
1975−1976   
House Physician, Guy's Hospital
1969−1975   
Technician, Dr A Rogers, Physiology Dept, Bristol University
 
 
Loometöö
Editor: Journal of Psychopharmacology since 1989 Editorial Boards: Journal of Biological Society, International Clinical Psychopharmacology, International Journal of Psychiatry in Clinical Practice, Anxiety, European Journal of Pharmacology .
 
 
Teenistuskäigu lisainfo
MISCELLANEOUS:
Consultant to Ministry of Defence 1990-date
Member DSAC [Defence Sciences Advisory Council] 2005- date
Member of the EC Working Party on PET and SPECT ligands 1992
UBHT - Medicines Advisory committee 1993-2000
UBHT - Medical Research committee 1993-1997
District psychiatric training committee 1993-2000
Faculty Member, European Certificate in Anxiety Disorder 1993-1995
Director of the European Certificate of Affective disorders course 1995-date
External Examiner, University of Birmingham 1994-1997
British Pharmacological Society, Clinical Pharmacology Section Expert 1996-date
CINP International Scientific Program Committee member1996-1998
CINP Nominating Committee member 1996-1998
ECNP Council Member 1998-date
ECNP President-elect 2007
Trustee of the Sir Robert Mond Memorial Trust 1998-date
Patron of NH Phobic Society 1999
World Psychiatric Association, Co-Chair Section on Biological Psychiatry 1999-2001
BBSRC Functional Imaging Course Board Member 1999-2001
NICE reviewer for depression, panic and social anxiety disorders and the Z-drug hypnotics 1999-date ;

Kvalifikatsioon

 
 
Teaduspreemiad ja tunnustused
1984, David J. Nutt, Royal College of Psychiatrists Research Prize
1975, David J. Nutt, Mental Health Trust Essay Competition: "The Significance of Life Changes in the Development of Illness"
1975, David J. Nutt, First Clinical Prize
 
 
Teadustöö põhisuunad
VALDKOND: 3. Terviseuuringud; 3.7. Kliiniline meditsiin; PÕHISUUND: Development of several anxiety provoking paradigms including the use of CO2 as an anxiety challenge in healthy volunteers. Use of drug treatments and challenge tests to determine the role of selected neurotransmitters in panic disorder and social anxiety disorder, and the use of CO2 to study effects of anxiolytics and antidepressants. Experimental and clinical evaluation of new pharmacological agents, such as various antidepressants and GABA-directed agents (eg, partial inverse agonist). The discovery of the imidazoline receptor and development of putative ligands for this new receptor system. Brain imaging and other experimental studies in people addicted to heroin or alcohol to elucidate the neurochemical and anatomical basis of phenomena such as tolerance and craving. European and UK cohort studies on panic social phobia and insomnia plus application of several experimental research paradigms to evaluation of sleep in selected groups (eg, people with depressive disorders, alcoholism). Extensive animal and some human work on epilepsy and electroconvulsive therapy, including the neurochemical factors that affect seizure thresholds.
 
 
Lisainfo
MISCELLANEOUS:
Consultant to Ministry of Defence 1990-date
Member DSAC [Defence Sciences Advisory Council] 2005- date
Member of the EC Working Party on PET and SPECT ligands 1992
UBHT - Medicines Advisory committee 1993-2000
UBHT - Medical Research committee 1993-1997
District psychiatric training committee 1993-2000
Faculty Member, European Certificate in Anxiety Disorder 1993-1995
Director of the European Certificate of Affective disorders course 1995-date
External Examiner, University of Birmingham 1994-1997
British Pharmacological Society, Clinical Pharmacology Section Expert 1996-date
CINP International Scientific Program Committee member1996-1998
CINP Nominating Committee member 1996-1998
ECNP Council Member 1998-date
ECNP President-elect 2007
Trustee of the Sir Robert Mond Memorial Trust 1998-date
Patron of NH Phobic Society 1999
World Psychiatric Association, Co-Chair Section on Biological Psychiatry 1999-2001
BBSRC Functional Imaging Course Board Member 1999-2001
NICE reviewer for depression, panic and social anxiety disorders and the Z-drug hypnotics 1999-date
RESEARCH GRANTS
Oxford University
Wellcome Trust (with Dr H Little) 1983-1984 £15K
Masons Trust 1984 £4K
Nuffield Foundation 1985 £6K
Wellcome Trust (with Prof M Gelder)1985-1989 £140K
Nuffield Foundation 1985 £5K
University of Bristol
Reckitt & Colman 1988-1992 £28000K
MRC CASE awards x 2 1989-1992 £50K
National Institute of Mental Health, USA1992 £22K
National Institute of Alcohol Abuse, USA 1992-1994 £100K
Upjohn-Duphar 1992-1993 £40K
SmithKline Beecham 1992-1993 £30K
MRC project grant (with Prof A Smith) 1993 £29K
MRC CASE award 1993-1996 £30K
UCB Pharma 1993-1996 £450K
UBHT medical research trust 1993 £6K
Roche (with Prof A Smith) 1993-1995 £180K
Burden trust 1993 £5K
Pfizer 1993-1994 £40K
Wellcome Trust 1994 £53K
Wellcome training fellowship (Dr Malizia) 1994-1996 £143K
SW Region (with Dr Evans & Prof Morgan)1994-1995 £29K
Wellcome Trust 1994-1996 £58K
MRC project grant (with Prof Lewis)1994-1995 £45K
MRC project grant (with Dr Myles, Prof Lewis) 1994-1995£40K
NHS research initiative (with Dr Myles) 1995-1997 £60K
MOD 1994-1997 £65K
MRC project grant (with Dr Myles)1994-1995 £37K
Lilly 1995-1996 £88K
Proctor and Gamble (with Prof Smith)1995-1997 £233K
BBSRC CASE (with Knoll Pharmaceuticals)1995-1998 £45K
MRC ROPA (with Prof Lewis)1995-1998 £129K
Wellcome Trust 1995-1997 £170K
NHS Executive S&W 1995-1996 £40K
Interneuron Pharmaceuticals1996-1997 £50K
Wyeth Laboratories 1995-1997 £50K
NHS Executive S&W 1995-1997 £60K
MRC project grant 1996-1997 £41K
MOD 1996 £12K
Wellcome Trust 1996-1998 £140K
Servier, France 1996-1997 £95K
Wellcome Trust 1996-1998 £85K
Merck Pharmaceuticals 1997-1998 £47K
MRC ROPA 1997-1999 £92K
MRC project grant 1997-2000 £243K
MRC Programme grant 1997-2002 £1,059K
Organon Pharmaceuticals 1997-1998 £50K
UBHT Research grant 1998 £4K
DERA CBDE grant 1998-1999 £10K
Pharmacia & Upjohn 1998 £40K
BBSRC CASE (with Knoll Pharmaceuticals)1998-2001 £45K
DERA CBDE grant 1998-2001 £50K
Noise on Health (with Prof Smith)1998-2001 £120K
NIMH 1999-2001 £103K
Wellcome Trust 2000-2003 £204K
Bial Foundation 2001-2003 £20K
Wellcome Trust 2004-2005 £85K

Publikatsioonid

Klass
Aasta
Publikatsioon
 
1.1.
2012
1.1.
2011
1.1.
2010
1.1.
2010
5.2.
2010
1.1.
2009
1.1.
2009
1.3.
2009
1.1.
2006
22.04.2019
16.04.1951
0117 331 3
d.nutt@imperial.ac.uk

Career

Institution(s) and position(s)
01.01.2009–...   
Head of Department of Neuropsychopharmacology, Imperial College London
2006–...   
University of Tartu, Faculty of Medicine, Other staff (1,00)
01.01.1988–...   
Honorary Consultant Psychiatrist, United Bristol Healthcare Trust
01.01.2003–31.12.2009   
Head of the Department of Community Based Medicine
01.01.1994–31.12.2009   
Professor of Psychopharmacology, University of Bristol
01.01.1988–31.12.2009   
Director, Psychopharmacology Unit, University of Bristol
 
 
Education
2002–...   
FMedSci
2002–...   
FRCP
1994–...   
FRCPsych (UK)
1983–...   
MRCPsych (UK)
1982–...   
DM (Oxon)
1981–...   
MA, MB, BChir (Oxon) (by Incorporation).
1977–...   
MRCP (London)
1975–...   
MB BChir (Cantab)
1972–...   
BA (Cantab) 1st in both parts of Medical Sciences Tripos, including part Ib Psychology 2:2 Part II, Physiology
 
 
R&D related managerial and administrative work
2009−...   
Head of Department of Neuropsychopharmacology, Imperial College London
2003−2009   
Head of the Department of Community Based Medicine
2000−2003   
Dean of Clinical Medicine and Dentistry
1997−2003   
Head of Department of Clinical Medicine
1996−1997   
Head, Division of Psychiatry, University of Bristol
1994−2009   
Professor of Psychopharmacology, University of Bristol
1988−2009   
Director, Psychopharmacology Unit, University of Bristol; Senior Research Fellow in Pharmacology and in Mental Health; Honorary Consultant Psychiatrist, United Bristol Healthcare Trust.
1986−1988   
Fogarty Visiting Scientist NIH and Chief of the Section of Clinical Science, National Institute on Alcohol Abuse and Alcoholism, Bethesda, Maryland.
1985−1986   
Wellcome Senior Fellow in Clinical Science; University Department of Psychiatry, Warneford Hospital, Oxford. Honorary Consultant Psychiatrist.
1983−1985   
Lecturer in Psychiatry, University of Oxford, attached to the Psychopharmacology Research Unit, Littlemore Hospital, Oxford.
1982−1983   
Registrar in Psychiatry on the Oxford Rotational Training Scheme.
1978−1978   
Senior House Officer, Psychiatry, Guy's Hospital
1978−1982   
Clinical Scientist in the MRC Unit of Clinical Pharmacology, Radcliffe Infirmary, Oxford (Professor D G Grahame Smith).
1977−1978   
Senior House Officer, Neurology, St. Mary's Hospital, Paddington
1976−1976   
House Surgeon, Royal Sussex County Hospital, Brighton
1976−1976   
Senior House Officer, Dermatology, Guy's Hospital
1975−1976   
House Physician, Guy's Hospital
1969−1975   
Technician, Dr A Rogers, Physiology Dept, Bristol University
 
 
Creative work
Editor: Journal of Psychopharmacology since 1989 Editorial Boards: Journal of Biological Society, International Clinical Psychopharmacology, International Journal of Psychiatry in Clinical Practice, Anxiety, European Journal of Pharmacology .
 
 
Additional career information
MISCELLANEOUS:
Consultant to Ministry of Defence 1990-date
Member DSAC [Defence Sciences Advisory Council] 2005- date
Member of the EC Working Party on PET and SPECT ligands 1992
UBHT - Medicines Advisory committee 1993-2000
UBHT - Medical Research committee 1993-1997
District psychiatric training committee 1993-2000
Faculty Member, European Certificate in Anxiety Disorder 1993-1995
Director of the European Certificate of Affective disorders course 1995-date
External Examiner, University of Birmingham 1994-1997
British Pharmacological Society, Clinical Pharmacology Section Expert 1996-date
CINP International Scientific Program Committee member1996-1998
CINP Nominating Committee member 1996-1998
ECNP Council Member 1998-date
ECNP President-elect 2007
Trustee of the Sir Robert Mond Memorial Trust 1998-date
Patron of NH Phobic Society 1999
World Psychiatric Association, Co-Chair Section on Biological Psychiatry 1999-2001
BBSRC Functional Imaging Course Board Member 1999-2001
NICE reviewer for depression, panic and social anxiety disorders and the Z-drug hypnotics 1999-date
RESEARCH GRANTS
Oxford University
Wellcome Trust (with Dr H Little) 1983-1984 £15K
Masons Trust 1984 £4K
Nuffield Foundation 1985 £6K
Wellcome Trust (with Prof M Gelder)1985-1989 £140K
Nuffield Foundation 1985 £5K
University of Bristol
Reckitt & Colman 1988-1992 £28000K
MRC CASE awards x 2 1989-1992 £50K
National Institute of Mental Health, USA1992 £22K
National Institute of Alcohol Abuse, USA 1992-1994 £100K
Upjohn-Duphar 1992-1993 £40K
SmithKline Beecham 1992-1993 £30K
MRC project grant (with Prof A Smith) 1993 £29K
MRC CASE award 1993-1996 £30K
UCB Pharma 1993-1996 £450K
UBHT medical research trust 1993 £6K
Roche (with Prof A Smith) 1993-1995 £180K
Burden trust 1993 £5K
Pfizer 1993-1994 £40K
Wellcome Trust 1994 £53K
Wellcome training fellowship (Dr Malizia) 1994-1996 £143K
SW Region (with Dr Evans & Prof Morgan)1994-1995 £29K
Wellcome Trust 1994-1996 £58K
MRC project grant (with Prof Lewis)1994-1995 £45K
MRC project grant (with Dr Myles, Prof Lewis) 1994-1995£40K
NHS research initiative (with Dr Myles) 1995-1997 £60K
MOD 1994-1997 £65K
MRC project grant (with Dr Myles)1994-1995 £37K
Lilly 1995-1996 £88K
Proctor and Gamble (with Prof Smith)1995-1997 £233K
BBSRC CASE (with Knoll Pharmaceuticals)1995-1998 £45K
MRC ROPA (with Prof Lewis)1995-1998 £129K
Wellcome Trust 1995-1997 £170K
NHS Executive S&W 1995-1996 £40K
Interneuron Pharmaceuticals1996-1997 £50K
Wyeth Laboratories 1995-1997 £50K
NHS Executive S&W 1995-1997 £60K
MRC project grant 1996-1997 £41K
MOD 1996 £12K
Wellcome Trust 1996-1998 £140K
Servier, France 1996-1997 £95K
Wellcome Trust 1996-1998 £85K
Merck Pharmaceuticals 1997-1998 £47K
MRC ROPA 1997-1999 £92K
MRC project grant 1997-2000 £243K
MRC Programme grant 1997-2002 £1,059K
Organon Pharmaceuticals 1997-1998 £50K
UBHT Research grant 1998 £4K
DERA CBDE grant 1998-1999 £10K
Pharmacia & Upjohn 1998 £40K
BBSRC CASE (with Knoll Pharmaceuticals)1998-2001 £45K
DERA CBDE grant 1998-2001 £50K
Noise on Health (with Prof Smith)1998-2001 £120K
NIMH 1999-2001 £103K
Wellcome Trust 2000-2003 £204K
Bial Foundation 2001-2003 £20K
Wellcome Trust 2004-2005 £85K;

Qualifications

 
 
Field of research
FIELD OF RESEARCH: 3. Health; 3.7. Clinical Medicine

Publications

Category
Year
Publication
 
1.1.
2012
1.1.
2011
1.1.
2010
1.1.
2010
5.2.
2010
1.1.
2009
1.1.
2009
1.3.
2009
1.1.
2006
22.04.2019
  • Leitud 1 kirjet
ProgrammLiikNumberNimiProjekti algusProjekti lõppVastutav täitjaAsutusFinantseerijapoolne rahastamine
ETFETF7034SSTP ravivastust ennustavad geneetilised faktorid paanikahäirega haigetel01.01.200731.12.2010Eduard MaronTartu Ülikool, Arstiteaduskond57 024,27 EUR